Proceeding contribution from Lord Alton of Liverpool (Crossbench) in the House of Lords on Monday, 4 February 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [HL].
Human Fertilisation and Embryology Bill [HL]
My Lords, who would determine whether embryos would be used in therapies rather than just in research, as currently? What expertise exists within the Human Fertilisation and Embryology Authority to determine issues surrounding the kinds of diseases that the noble Lord, Lord Walton of Detchant, has mentioned? Furthermore, what assessment has been made of safety hazards and risks that there might be because, where foetal cells have been used in the United States for the treatment of sufferers of Parkinson’s, those treatments had to be withdrawn owing to the irremediable damage that they did?
Secondary information
- Type
- Proceeding contribution
- Reference
- 698 c863
- Session
- 2007-08
- Chamber / Committee
- House of Lords chamber
- Subjects
- Disclosure of information Codes of practice Fertility Licensing Human embryo experiments Diseases Donors Human Fertilisation and Embryology Authority Ethics IVF Parents Regulation Registration of births, deaths, marriages and civil partnerships Research Stem cells
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 00:08:25 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442241
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442241
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_442241